Invesaro

Stocks Comparison

Cadre vs Enovis: revenue, profit, margins and growth compared

Cadre brought in $610.3M of revenue in fiscal 2025, Enovis $2.2B in fiscal 2025. Revenue changed by +7.5% at Cadre and +6.7% at Enovis on the year before, so Cadre grew faster. Cadre kept 7.2% of its revenue as net profit, Enovis -52.7%. Free cash flow was $56.8M at Cadre and $19.9M at Enovis.

Side by side, latest fiscal year

CDREENOV
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$610.3M$2.2B
Revenue growth+7.5%+6.7%
Net income$44.1M-$1.2B
Net margin7.2%-52.7%
Free cash flow$56.8M$19.9M
Free cash flow margin9.3%0.9%
Earnings per share (diluted)$1.02-$20.75
Cash$122.9M$36.4M
Debt$307.3M$1.3B
Price to earnings25.9n/a
Market value$1.1B$1.1B
Dividend yield0.36%n/a
Rank by revenue in sector#179 of 523 · Health care#102 of 523 · Health care

Over the years

Revenue
CDRE FY2021: $404.6MCDRE FY2021: $427.3MCDRE FY2022: $457.8MCDRE FY2023: $482.5MCDRE FY2024: $567.6MCDRE FY2025: $610.3MENOV FY2018: $3.7BENOV FY2019: $3.3BENOV FY2020: $1.1BENOV FY2021: $1.4BENOV FY2022: $1.6BENOV FY2023: $1.7BENOV FY2024: $2.1BENOV FY2025: $2.2BFY18FY19FY20FY21FY22FY23FY24FY25
CDRE $610.3MENOV $2.2B
Net income
CDRE FY2021: $38.5MCDRE FY2021: $12.7MCDRE FY2022: $5.8MCDRE FY2023: $38.6MCDRE FY2024: $36.1MCDRE FY2025: $44.1MENOV FY2018: $140.2MENOV FY2019: -$527.6MENOV FY2020: $42.6MENOV FY2021: $71.7MENOV FY2022: -$13.3MENOV FY2023: -$33.3MENOV FY2024: -$825.5MENOV FY2025: -$1.2BFY18FY19FY20FY21FY22FY23FY24FY25
CDRE $44.1MENOV -$1.2B
Net margin
CDRE FY2021: 9.5%CDRE FY2021: 3.0%CDRE FY2022: 1.3%CDRE FY2023: 8.0%CDRE FY2024: 6.4%CDRE FY2025: 7.2%ENOV FY2018: 3.8%ENOV FY2019: -15.9%ENOV FY2020: 3.8%ENOV FY2021: 5.0%ENOV FY2022: -0.9%ENOV FY2023: -1.9%ENOV FY2024: -39.2%ENOV FY2025: -52.7%FY18FY19FY20FY21FY22FY23FY24FY25
CDRE 7.2%ENOV -52.7%
Revenue growth
CDRE FY2021: +5.6%CDRE FY2022: +7.1%CDRE FY2023: +5.4%CDRE FY2024: +17.6%CDRE FY2025: +7.5%ENOV FY2019: -9.3%ENOV FY2020: -66.3%ENOV FY2021: +27.3%ENOV FY2022: +9.6%ENOV FY2023: +9.2%ENOV FY2024: +23.5%ENOV FY2025: +6.7%FY19FY20FY21FY22FY23FY24FY25
CDRE +7.5%ENOV +6.7%
Free cash flow
CDRE FY2021: $40.7MCDRE FY2021: $37.3MCDRE FY2022: $41.9MCDRE FY2023: $66.5MCDRE FY2024: $26.1MCDRE FY2025: $56.8MENOV FY2018: $156.7MENOV FY2019: $5.5MENOV FY2020: $187.2MENOV FY2021: $251.9MENOV FY2022: -$161.3MENOV FY2023: $12.8MENOV FY2024: -$67.2MENOV FY2025: $19.9MFY18FY19FY20FY21FY22FY23FY24FY25
CDRE $56.8MENOV $19.9M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cadre and Enovis

Which is bigger by revenue, Cadre or Enovis?

Enovis is bigger by revenue: $2.2B in fiscal 2025, against $610.3M for Cadre in fiscal 2025.

Which keeps more of its revenue as profit, Cadre or Enovis?

Cadre had a net margin of 7.2% in fiscal 2025; Enovis had -52.7% in fiscal 2025.

Which grew revenue faster, Cadre or Enovis?

In their latest fiscal years revenue changed by +7.5% at Cadre and +6.7% at Enovis.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies